Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

[Human genetics in atypical hemolytic uremic syndrome-its role in diagnosis and treatment].

Knoop M, Haller H, Menne J.

Internist (Berl). 2018 Jul 11. doi: 10.1007/s00108-018-0455-9. [Epub ahead of print] Review. German.

PMID:
29995248
2.

Probing depth is an independent risk factor for HbA1c levels in diabetic patients under physical training: a cross-sectional pilot-study.

Wernicke K, Zeissler S, Mooren FC, Frech T, Hellmann S, Stiesch M, Grischke J, Linnenweber S, Schmidt B, Menne J, Melk A, Bauer P, Hillebrecht A, Eberhard J.

BMC Oral Health. 2018 Mar 16;18(1):46. doi: 10.1186/s12903-018-0491-9.

3.

Molecular Mechanisms and Treatment Strategies in Diabetic Nephropathy: New Avenues for Calcium Dobesilate-Free Radical Scavenger and Growth Factor Inhibition.

Haller H, Ji L, Stahl K, Bertram A, Menne J.

Biomed Res Int. 2017;2017:1909258. doi: 10.1155/2017/1909258. Epub 2017 Sep 26. Review.

4.

Predictors for the development of microalbuminuria and interaction with renal function.

Chatzikyrkou C, Menne J, Izzo J, Viberti G, Rabelink T, Ruilope LM, Rump C, Mertens PR, Haller H.

J Hypertens. 2017 Dec;35(12):2501-2509. doi: 10.1097/HJH.0000000000001491.

PMID:
29035939
5.

Chronic Deep Brain Stimulation Decreases Blood Pressure and Sympathetic Nerve Activity in a Drug- and Device-Resistant Hypertensive Patient.

O'Callaghan EL, Hart EC, Sims-Williams H, Javed S, Burchell AE, Papouchado M, Tank J, Heusser K, Jordan J, Menne J, Haller H, Nightingale AK, Paton JF, Patel NK.

Hypertension. 2017 Apr;69(4):522-528. doi: 10.1161/HYPERTENSIONAHA.116.08972. Epub 2017 Feb 27. No abstract available.

PMID:
28242717
6.

C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria.

Menne J, Eulberg D, Beyer D, Baumann M, Saudek F, Valkusz Z, Więcek A, Haller H; Emapticap Study Group.

Nephrol Dial Transplant. 2017 Feb 1;32(2):307-315. doi: 10.1093/ndt/gfv459.

7.

[Invasive treatment of hypertension : Update 2016].

Menne J, Wachter R.

Internist (Berl). 2016 Sep;57(9):871-8. doi: 10.1007/s00108-016-0116-9. Review. German.

PMID:
27558391
8.

Clinical and Laboratory Consequences of Platelet Transfusion in Shiga Toxin-Mediated Hemolytic Uremic Syndrome.

Beneke J, Sartison A, Kielstein JT, Haller H, Nitschke M, Kunzendorf U, Loos S, Kemper MJ, Stahl RA, Menne J; German 2011 STEC-HUS outbreak study group.

Transfus Med Rev. 2017 Jan;31(1):51-55. doi: 10.1016/j.tmrv.2016.06.004. Epub 2016 Jun 21.

PMID:
27468945
9.

Low-dose erythropoietin promotes wound-healing of ulcers in diabetics: Evidence from a phase-IIa clinical study.

Chatzikyrkou C, Bahlmann FH, Sushakova N, Scurt FG, Menne J, Nawroth P, Mertens PR, Haller H.

Diabetes Metab. 2016 Dec;42(6):466-470. doi: 10.1016/j.diabet.2016.05.010. Epub 2016 Jun 17. No abstract available.

PMID:
27324461
10.

Physiology Unmasks Hypertension.

Heusser K, Brinkmann J, Topalidis W, Menne J, Haller H, Berliner D, Luft FC, Tank J, Jordan J.

Hypertension. 2016 Aug;68(2):252-6. doi: 10.1161/HYPERTENSIONAHA.116.07759. Epub 2016 Jun 13. No abstract available.

PMID:
27296991
11.

Short- and long-term effects of the use of RAAS blockers immediately after renal transplantation.

Chatzikyrkou C, Eichler J, Karch A, Clajus C, Scurt FG, Ramackers W, Lehner F, Menne J, Haller H, Mertens PR, Schiffer M.

Blood Press. 2017 Feb;26(1):30-38. doi: 10.1080/08037051.2016.1182856. Epub 2016 May 19.

PMID:
27195820
12.

Protein kinase C α inhibition prevents peritoneal damage in a mouse model of chronic peritoneal exposure to high-glucose dialysate.

Wang L, Balzer MS, Rong S, Menne J, von Vietinghoff S, Dong L, Gueler F, Jang MS, Xu G, Timrott K, Tkachuk S, Hiss M, Haller H, Shushakova N.

Kidney Int. 2016 Jun;89(6):1253-67. doi: 10.1016/j.kint.2016.01.025. Epub 2016 Mar 25.

PMID:
27142955
13.

Finerenone: a New Mineralocorticoid Receptor Antagonist Without Hyperkalemia: an Opportunity in Patients with CKD?

Haller H, Bertram A, Stahl K, Menne J.

Curr Hypertens Rep. 2016 Apr;18(5):41. doi: 10.1007/s11906-016-0649-2. Review.

PMID:
27115525
14.

Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.

Fakhouri F, Hourmant M, Campistol JM, Cataland SR, Espinosa M, Gaber AO, Menne J, Minetti EE, Provôt F, Rondeau E, Ruggenenti P, Weekers LE, Ogawa M, Bedrosian CL, Legendre CM.

Am J Kidney Dis. 2016 Jul;68(1):84-93. doi: 10.1053/j.ajkd.2015.12.034. Epub 2016 Mar 21.

15.

Involvement of Angiopoietin-2 and Tie2 Receptor Phosphorylation in STEC-HUS Mediated by Escherichia coli O104:H4.

Lukasz A, Beneke J, Thamm K, Kielstein JT, Menne J, Mikesch JH, Schmidt BM, Haller H, Kümpers P, David S, Schiffer M.

Mediators Inflamm. 2015;2015:670248. doi: 10.1155/2015/670248. Epub 2015 Dec 24.

16.

Acute Response to Unilateral Unipolar Electrical Carotid Sinus Stimulation in Patients With Resistant Arterial Hypertension.

Heusser K, Tank J, Brinkmann J, Menne J, Kaufeld J, Linnenweber-Held S, Beige J, Wilhelmi M, Diedrich A, Haller H, Jordan J.

Hypertension. 2016 Mar;67(3):585-91. doi: 10.1161/HYPERTENSIONAHA.115.06486. Epub 2016 Feb 1.

17.

Ultrasound findings in EHEC-associated hemolytic-uremic syndrome and their clinical relevance.

Reising A, Hafer C, Hiss M, Kielstein JT, Menne J, Gueler F, Beneke J, Linnenweber-Held S, Haller H, Einecke G.

Int Urol Nephrol. 2016 Apr;48(4):561-70. doi: 10.1007/s11255-015-1194-7. Epub 2016 Jan 12.

PMID:
26759326
18.

Monocyte chemoattractant protein-1 and the kidney.

Haller H, Bertram A, Nadrowitz F, Menne J.

Curr Opin Nephrol Hypertens. 2016 Jan;25(1):42-9. doi: 10.1097/MNH.0000000000000186. Review.

PMID:
26625862
19.

Spike rate of multi-unit muscle sympathetic nerve fibers after catheter-based renal nerve ablation.

Tank J, Heusser K, Brinkmann J, Schmidt BM, Menne J, Bauersachs J, Haller H, Diedrich A, Jordan J.

J Am Soc Hypertens. 2015 Oct;9(10):794-801. doi: 10.1016/j.jash.2015.07.012. Epub 2015 Jul 31.

20.

Electrical Atrial Alternans Recorded by Cardiac Rhythm Devices during Atrial Flutter.

Barold SS, Kucher A, Menne J, Stroobandt RX.

Pacing Clin Electrophysiol. 2015 Oct;38(10):1231-5. doi: 10.1111/pace.12629. Epub 2015 May 4. No abstract available.

PMID:
25789963
21.

[Rare forms of hypertension : From pheochromocytoma to vasculitis].

Haller H, Limbourg F, Schmidt BM, Menne J.

Internist (Berl). 2015 Mar;56(3):255-62. doi: 10.1007/s00108-014-3571-1. German.

PMID:
25700646
22.

[Interventional strategies in hypertension management].

Wachter R, Menne J.

Internist (Berl). 2015 Mar;56(3):240-7. doi: 10.1007/s00108-014-3569-8. German.

PMID:
25693902
23.

Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides.

Schanstra JP, Zürbig P, Alkhalaf A, Argiles A, Bakker SJ, Beige J, Bilo HJ, Chatzikyrkou C, Dakna M, Dawson J, Delles C, Haller H, Haubitz M, Husi H, Jankowski J, Jerums G, Kleefstra N, Kuznetsova T, Maahs DM, Menne J, Mullen W, Ortiz A, Persson F, Rossing P, Ruggenenti P, Rychlik I, Serra AL, Siwy J, Snell-Bergeon J, Spasovski G, Staessen JA, Vlahou A, Mischak H, Vanholder R.

J Am Soc Nephrol. 2015 Aug;26(8):1999-2010. doi: 10.1681/ASN.2014050423. Epub 2015 Jan 14.

24.

Long-term effects of 3-month telemetric blood pressure intervention in patients with inadequately treated arterial hypertension.

Neumann CL, Menne J, Schettler V, Hagenah GC, Brockes C, Haller H, Schulz EG.

Telemed J E Health. 2015 Mar;21(3):145-50. doi: 10.1089/tmj.2014.0058. Epub 2015 Jan 8.

PMID:
25569481
25.

Prevention of electrocardiographic left ventricular remodeling by the angiotensin receptor blocker olmesartan in patients with type 2 diabetes.

Raff U, Ott C, Ruilope LM, Menne J, Haller H, Schmieder RE.

J Hypertens. 2014 Nov;32(11):2267-76; discussion 2276. doi: 10.1097/HJH.0000000000000313.

PMID:
25275251
26.

Renal PKC-ε deficiency attenuates acute kidney injury and ischemic allograft injury via TNF-α-dependent inhibition of apoptosis and inflammation.

Rong S, Hueper K, Kirsch T, Greite R, Klemann C, Mengel M, Meier M, Menne J, Leitges M, Susnik N, Meier M, Haller H, Shushakova N, Gueler F.

Am J Physiol Renal Physiol. 2014 Sep 15;307(6):F718-26. doi: 10.1152/ajprenal.00372.2013. Epub 2014 Jul 23.

28.

Eligibility for renal denervation: experience at 11 European expert centers.

Persu A, Jin Y, Baelen M, Vink E, Verloop WL, Schmidt B, Blicher MK, Severino F, Wuerzner G, Taylor A, Pechère-Bertschi A, Jokhaji F, Fadl Elmula FE, Rosa J, Czarnecka D, Ehret G, Kahan T, Renkin J, Widimsky J Jr, Jacobs L, Spiering W, Burnier M, Mark PB, Menne J, Olsen MH, Blankestijn PJ, Kjeldsen S, Bots ML, Staessen JA; European Network Coordinating research on REnal Denervation Consortium.

Hypertension. 2014 Jun;63(6):1319-25. doi: 10.1161/HYPERTENSIONAHA.114.03194. Epub 2014 Mar 24.

PMID:
24664290
29.

Limited acute influences of electrical baroreceptor activation on insulin sensitivity and glucose delivery: a randomized, double-blind, crossover clinical study.

May M, Ahrens J, Menne J, Haller H, Beige J, Eckert S, Jordan J, Engeli S.

Diabetes. 2014 Aug;63(8):2833-7. doi: 10.2337/db13-1651. Epub 2014 Mar 19.

30.

Serum neutrophil gelatinase-associated lipocalin (NGAL) in patients with Shiga toxin mediated haemolytic uraemic syndrome (STEC-HUS).

Lukasz A, Beneke J, Menne J, Vetter F, Schmidt BM, Schiffer M, Haller H, Kümpers P, Kielstein JT.

Thromb Haemost. 2014 Feb;111(2):365-72. doi: 10.1160/TH13-05-0387. Epub 2013 Oct 31.

PMID:
24172823
31.

Thromboembolism in renal transplant artery due to atrial fibrillation.

Müller-Deile J, Schwarz A, Menne J.

Clin Nephrol Case Stud. 2013 Oct 28;1:10-13. doi: 10.5414/CNCS108029. eCollection 2013.

32.

Structure and function of large arteries in hypertension in relation to oxidative stress markers.

Klima Ł, Kawecka-Jaszcz K, Stolarz-Skrzypek K, Menne J, Fijorek K, Olszanecka A, Wojciechowska W, Bilo G, Czarnecka D.

Kardiol Pol. 2013;71(9):917-23. doi: 10.5603/KP.2013.0226.

33.

Diabetes: Legacy effects of RAS blockade in diabetes mellitus.

Chatzikyrkou C, Menne J.

Nat Rev Nephrol. 2013 Oct;9(10):566-8. doi: 10.1038/nrneph.2013.173. Epub 2013 Sep 10. No abstract available.

PMID:
24018412
34.

Zinc-alpha2-glycoprotein in patients with acute and chronic kidney disease.

Sörensen-Zender I, Beneke J, Schmidt BM, Menne J, Haller H, Schmitt R.

BMC Nephrol. 2013 Jul 12;14:145. doi: 10.1186/1471-2369-14-145.

35.

Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.

Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nürnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C.

N Engl J Med. 2013 Jun 6;368(23):2169-81. doi: 10.1056/NEJMoa1208981.

36.

Truly refractory hypertension.

Schroeder C, Heusser K, Brinkmann J, Menne J, Oswald H, Haller H, Jordan J, Tank J, Luft FC.

Hypertension. 2013 Aug;62(2):231-5. doi: 10.1161/HYPERTENSIONAHA.113.01240. Epub 2013 May 20. No abstract available.

PMID:
23690343
37.

Body weight telemetry is useful to reduce interdialytic weight gain in patients with end-stage renal failure on hemodialysis.

Neumann CL, Wagner F, Menne J, Brockes C, Schmidt-Weitmann S, Rieken EM, Schettler V, Hagenah GC, Matzath S, Zimmerli L, Haller H, Schulz EG.

Telemed J E Health. 2013 Jun;19(6):480-6. doi: 10.1089/tmj.2012.0188. Epub 2013 Apr 24.

38.

Response to catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to- control hypertensive patients: prospective case series.

Jordan J, Heusser K, Brinkmann J, Schmidt B, Menne J, Klein G, Bauersachs J, Haller H, Sweep FC, Diedrich A, Tank J.

Hypertension. 2013 Feb;61(2):e18. No abstract available. Erratum in: Hypertension. 2013 May;61(5):e54. Brinkmann, Julia [added]; Schmidt, Bernhard [added]; Menne, Jan [added]; Klein, Gunnar [added]; Bauersachs, Johann [added]; Haller, Hermann [added]; Sweep, Fred C [added]; Diedrich, Andre [added].

PMID:
23444462
39.

Response to blood pressure and sympathetic nervous system response to renal denervation.

Heusser K, Tank J, Brinkmann J, Schmidt B, Menne J, Klein G, Bauersachs J, Haller H, Sweep FC, Diedrich A, Jordan J.

Hypertension. 2013 Feb;61(2):e14. No abstract available. Erratum in: Hypertension. 2013 May;61(5):e53. Brinkmann, Julia [added]; Schmidt, Bernhard [added]; Menne, Jan [added]; Klein, Gunnar [added]; Bauersachs, Johann [added]; Haller, Hermann [added]; Sweep, Fred C [added]; Diedrich, Andre [added].

PMID:
23444460
40.

Response to catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to- control hypertensive patients.

Heusser H, Tank J, Brinkmann J, Schmidt B, Menne J, Klein G, Bauersachs J, Haller H, Sweep FC, Diedrich A, Jordan J.

Hypertension. 2013 Feb;61(2):e9-10. No abstract available. Erratum in: Hypertension. 2013 May;61(5):e52. Brinkmann, Julia [added] Schmidt, Bernhard [added]; Menne, Jan [added]; Klein, Gunnar [added]; Bauersachs, Johann [added]; Haller, Hermann [added]; Sweep, Fred C [added]; Diedrich, Andre [added].

PMID:
23444459
41.

Dual inhibition of classical protein kinase C-α and protein kinase C-β isoforms protects against experimental murine diabetic nephropathy.

Menne J, Shushakova N, Bartels J, Kiyan Y, Laudeley R, Haller H, Park JK, Meier M.

Diabetes. 2013 Apr;62(4):1167-74. doi: 10.2337/db12-0534. Epub 2013 Feb 22.

42.

Prevalence of microalbuminuria in type 2 diabetes: lessons learned from the ROADMAP study.

Ritz E, Menne J, Haller H.

Nephrol Dial Transplant. 2012 Dec;27 Suppl 4:iv28-30. doi: 10.1093/ndt/gfs424. No abstract available.

PMID:
23258807
43.

Resistant hypertension: baroreflex stimulation as a new tool.

Menne J, Jordan J, Linnenweber-Held S, Haller H.

Nephrol Dial Transplant. 2013 Feb;28(2):288-95. doi: 10.1093/ndt/gfs504. Epub 2012 Dec 6.

PMID:
23223217
44.

Targeting albuminuria in arterial hypertension and diabetes: how is it best achieved and what is its clinical relevance?

Chatzikyrkou C, Menne J.

J Hypertens. 2013 Jan;31(1):44-6. doi: 10.1097/HJH.0b013e32835c1604. No abstract available.

PMID:
23221930
45.

Olmesartan and intestinal adverse effects in the ROADMAP study.

Menne J, Haller H.

Mayo Clin Proc. 2012 Dec;87(12):1230-1; author reply 1232. doi: 10.1016/j.mayocp.2012.10.005. No abstract available.

46.

[Treatment of typical hemolytic-uremic syndrome. Knowledge gained from analyses of the 2011 E. coli outbreak].

Menne J, Kielstein JT, Wenzel U, Stahl RA.

Internist (Berl). 2012 Dec;53(12):1420-30. doi: 10.1007/s00108-012-3107-5. German.

PMID:
23179596
47.

Update on the ROADMAP clinical trial report: olmesartan for the prevention or delay of microalbuminuria development in type 2 diabetes.

Chatzikyrkou C, Menne J.

Expert Rev Cardiovasc Ther. 2012 Sep;10(9):1087-92. doi: 10.1586/erc.12.100. Review.

PMID:
23098143
48.

Circulating microRNAs in patients with Shiga-Toxin-producing E. coli O104:H4 induced hemolytic uremic syndrome.

Lorenzen JM, Menne J, Schmidt BM, Schmidt M, Martino F, Dietrich R, Samiri S, Worthmann H, Heeren M, Weissenborn K, Haller H, Schiffer M, Kielstein JT, Thum T.

PLoS One. 2012;7(10):e47215. doi: 10.1371/journal.pone.0047215. Epub 2012 Oct 11.

49.

Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series.

Brinkmann J, Heusser K, Schmidt BM, Menne J, Klein G, Bauersachs J, Haller H, Sweep FC, Diedrich A, Jordan J, Tank J.

Hypertension. 2012 Dec;60(6):1485-90. doi: 10.1161/HYPERTENSIONAHA.112.201186. Epub 2012 Oct 8.

PMID:
23045466
50.

Neurologic manifestations of E coli infection-induced hemolytic-uremic syndrome in adults.

Weissenborn K, Donnerstag F, Kielstein JT, Heeren M, Worthmann H, Hecker H, Schmitt R, Schiffer M, Pasedag T, Schuppner R, Tryc AB, Raab P, Hartmann H, Ding XQ, Hafer C, Menne J, Schmidt BM, Bültmann E, Haller H, Dengler R, Lanfermann H, Giesemann AM.

Neurology. 2012 Oct 2;79(14):1466-73. doi: 10.1212/WNL.0b013e31826d5f26. Epub 2012 Sep 19.

PMID:
22993286

Supplemental Content

Support Center